I think that the evidence is all but conclusive. Novartis most probably had substantial influence over the FDA.
This however is not any breach of due processes. The FDA realise on the input of outsiders including big pharmaceutical companies.
Now considering this, the Novartis partnership and that last bit of the announcement , "subject to ..." This is not just a cooling off period. The purpose of this is to insure that large corporations do not abuse there power and unfairly hold small companies to ransom. So we can now establish that we have a independent party review underway if not complete. Can you imagine what would happen if they ruled FDA was overwhelmingly influenced by Novartis and as such the FDA should have backed there own ODAC panel and approved our therapy.
Something to think about.
Good luck all.
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2021 - paradigm shift
MSB Trading 2021 - paradigm shift, page-801
-
- There are more pages in this discussion • 9,410 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32370 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 60258 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32370 | 0.925 |
9 | 98847 | 0.920 |
20 | 130822 | 0.915 |
15 | 194562 | 0.910 |
7 | 97027 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 60258 | 5 |
0.935 | 28119 | 2 |
0.940 | 20797 | 3 |
0.945 | 59774 | 3 |
0.950 | 26619 | 3 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |